Literature DB >> 6181802

Post-natal decline of fetal haemoglobin in homozygous sickle cell disease: relationship to parenteral Hb F levels.

K P Mason, Y Grandison, R J Hayes, B E Serjeant, G R Serjeant, S Vaidya, W G Wood.   

Abstract

The decline of fetal haemoglobin (Hb F) from birth to 6 years has been compared in a cohort of 266 Jamaican children with homozygous sickle cel (SS) disease and in 243 matched controls with a normal haemoglobin (AA) genotype. Hb F levels were significantly higher in the SS cases from 1 month onward but, unlike the normal controls, no sex difference was apparent. The Hb F levels in SS disease were significantly correlated with parental Hb F levels, suggesting that genetic factors regulating adult Hb F levels are active at earlier stages in development. Furthermore, some of these genetic determinants of Hb F production may be linked to the beta-like globin gene complex and be in linkage disequilibrium with the beta s allele.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 6181802     DOI: 10.1111/j.1365-2141.1982.tb03915.x

Source DB:  PubMed          Journal:  Br J Haematol        ISSN: 0007-1048            Impact factor:   6.998


  16 in total

1.  Fetal haemoglobin and early manifestations of homozygous sickle cell disease.

Authors:  K Bailey; J S Morris; P Thomas; G R Serjeant
Journal:  Arch Dis Child       Date:  1992-04       Impact factor: 3.791

2.  Exhaled carbon monoxide levels in children with sickle cell disease.

Authors:  Karl P Sylvester; Richard A Patey; Gerrard F Rafferty; David Rees; Swee Lay Thein; Anne Greenough
Journal:  Eur J Pediatr       Date:  2004-12-15       Impact factor: 3.183

3.  Sickle cell retinopathy in Jamaican children: further observations from a cohort study.

Authors:  J F Talbot; A C Bird; G H Maude; R W Acheson; B J Moriarty; G R Serjeant
Journal:  Br J Ophthalmol       Date:  1988-10       Impact factor: 4.638

4.  Long-term hydroxyurea therapy for infants with sickle cell anemia: the HUSOFT extension study.

Authors:  Jane S Hankins; Russell E Ware; Zora R Rogers; Lynn W Wynn; Peter A Lane; J Paul Scott; Winfred C Wang
Journal:  Blood       Date:  2005-10-01       Impact factor: 22.113

5.  G gamma beta+ hereditary persistence of fetal hemoglobin: cosmid cloning and identification of a specific mutation 5' to the G gamma gene.

Authors:  F S Collins; C J Stoeckert; G R Serjeant; B G Forget; S M Weissman
Journal:  Proc Natl Acad Sci U S A       Date:  1984-08       Impact factor: 11.205

Review 6.  Developmental genetics of the human haemoglobins.

Authors:  W G Wood; D J Weatherall
Journal:  Biochem J       Date:  1983-10-01       Impact factor: 3.857

Review 7.  Minireview: Clinical severity in sickle cell disease: the challenges of definition and prognostication.

Authors:  Charles T Quinn
Journal:  Exp Biol Med (Maywood)       Date:  2016-03-23

8.  Abdominal ultrasound with scintigraphic and clinical correlates in infants with sickle cell anemia: baseline data from the BABY HUG trial.

Authors:  M Beth McCarville; Zhaoyu Luo; Xiangke Huang; Renee C Rees; Zora R Rogers; Scott T Miller; Bruce Thompson; Ram Kalpatthi; Winfred C Wang
Journal:  AJR Am J Roentgenol       Date:  2011-06       Impact factor: 3.959

9.  The pediatric hydroxyurea phase III clinical trial (BABY HUG): challenges of study design.

Authors:  Bruce W Thompson; Scott T Miller; Zora R Rogers; Renee C Rees; Russell E Ware; Myron A Waclawiw; Rathi V Iyer; James F Casella; Lori Luchtman-Jones; Sohail Rana; Courtney D Thornburg; Ram V Kalpatthi; Julio C Barredo; R Clark Brown; Sharada Sarnaik; Thomas H Howard; Lori Luck; Winfred C Wang
Journal:  Pediatr Blood Cancer       Date:  2010-02       Impact factor: 3.167

10.  Hematological profile of sickle cell disease in central India.

Authors:  A V Shrikhande; A A Dani; J R Tijare; A K Agrawal
Journal:  Indian J Hematol Blood Transfus       Date:  2008-03-19       Impact factor: 0.900

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.